Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/9/2019
SIETES contiene 92806 citas

 
 
 1 a 4 de 4 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Glund S, Stangier J, Schmohl M, Gansser D, Norris S, Van Ryn J, Lang B, Ramael S, Moschetti V, Gruenenfelder F, Reilly P, Kreuzer J. Articles Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial. Lancet 2015;386:680-90. [Ref.ID 99494]
2.Enlace a cita original Cita con resumen
Clemens A, Van Ryn J, Sennewald R, Yamamura N, Stangier J, Feuring M, Härtter S. Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile. Eur J Clin Pharmacol 2012;68:607-16. [Ref.ID 92819]
3.
Van Ryn J, Kink-Eiband M, Kuritsch I, Feifel U, Hanft G, Wallenstein G, Trummlitz G, Pairet M. Meloxicam does not affect the antiplatelet effect of aspirin in healthy male and female volunteers. J Clin Pharmacol 2004;44:777-84. [Ref.ID 70517]
4.
Eisert WG, Van Ryn J, Kallmeyer M, Birk G, Hoffmann B, Schlachetzki F, Kubale R, Schneider E, Hoffmann U. Noninvasive method for measuring thrombus formation in patients after peripheral angioplasty using three-dimensional B-mode and color-coded doppler ultrasonography. J Clin Pharmacol 1997;37:79-83. [Ref.ID 31318]
Seleccionar todas
 
 1 a 4 de 4